Escitalopram’s Dual Efficacy in Treating Co-morbid Anxiety and Depression in American Males
Reading Time: 2 minutes Introduction Mental health disorders, such as anxiety and depression, pose significant challenges to individuals and healthcare systems worldwide. In the United States, these conditions are prevalent among males, often co-occurring and complicating treatment strategies. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), has been widely used to manage these disorders. This article delves into a cross-sectional study that examines the dual therapeutic benefits of escitalopram in American males suffering from co-morbid anxiety and depression, highlighting its efficacy and implications for clinical practice. Study Design and Methodology The cross-sectional study involved a cohort of American males diagnosed with both anxiety and depression....



